Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens to Market Molecular Imaging System for Researchers

By Biotechdaily staff writers
Posted on 15 Aug 2003
A molecular imaging system designed for use in the study of disease processes and drug development with features suited for in vivo imaging of mice or other small animals is to be exclusively marketed by Siemens Medical Solutions (Erlangen, Germany) in the United States, according to an agreement announced by Siemens and Gamma Medica, Inc. More...
(Northridge, CA, USA).

Called X-SPECT, the system combines the functional nuclear imaging technique of single photon emission computed tomography (SPECT) with the anatomical imaging provided by computed tomography (CT). The gantry is similar to popular clinical systems but on a smaller scale more suited for small animals in a laboratory setting. Gamma Medica develops and manufactures nuclear medical imaging cameras and equipment. X-SPECT is a second-generation system of the company's MicroSPECT system.


"When we started selling MicroSPECT systems, we were essentially creating a new market. Today, the product is aiding scientific research by furthering the understanding of disease, assisting in the search for treatments, and speeding up the process of getting drugs to the market,” noted Bradley E. Patt, Ph.D., president and CEO of Gamma Medica.





Related Links:
Siemens Medical Systems
Gamma Medica

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
All-in-One Molecular System
AIO M160
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.